Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin

NCT00814372 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

242

Enrollment

INDUSTRY

Sponsor class

Stopped MBX-102 did not meet the target efficacy profile of HbA1c change.

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: MBX-102
DRUG: Placebo
DRUG: Actos
DRUG: Metformin

Sponsor

Gilead Sciences